Ingvild Lobmaier Selected Research

Nuclear Receptor Co-Repressor 2

3/2022

Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in Osteoclastic Giant Cell-rich Tumors of Bone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingvild Lobmaier Research Topics

Disease

9	Neoplasms (Cancer) 07/2022 - 01/2016
2	Genetic Translocation (Chromosomal Translocation) 07/2022 - 06/2017
2	Sarcoma (Soft Tissue Sarcoma) 07/2022 - 01/2018
2	Osteosarcoma (Osteogenic Sarcoma) 09/2021 - 07/2017
2	Leiomyoma (Uterine Fibroids) 07/2021 - 11/2016
1	Neoplasm Metastasis (Metastasis) 07/2022
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 09/2020
1	Angiofibroma 09/2020
1	Solitary Fibrous Tumors 09/2020
1	Bone Cysts (Bone Cyst) 09/2020
1	Pleomorphic Adenoma 05/2020
1	Hemorrhage 01/2020
1	Osteoblastoma 09/2019
1	Hemangioendothelioma 07/2019
1	Myxoma (Myxomas) 03/2017
1	Hemangioma (Angioma) 03/2016
1	Leiomyosarcoma 01/2016
1	Benign Fibrous Histiocytoma (Dermatofibroma) 11/2015

Drug/Important Bio-Agent (IBA)

11	RNA (Ribonucleic Acid)IBA 07/2022 - 11/2015
3	Pyridinolcarbamate (P23)IBA 09/2020 - 11/2015
1	Intergenic DNA (Junk DNA)IBA 07/2022
1	Nuclear Receptor Co-Repressor 2IBA 03/2022
1	Histones (Histone)IBA 03/2022
1	pembrolizumabIBA 09/2021
1	Immunomodulating AgentsIBA 09/2021
1	Ubiquitin-Specific ProteasesIBA 09/2020
1	Carrier Proteins (Binding Protein)IBA 09/2020
1	LumicanIBA 09/2020
1	Capsules (Microcapsules)IBA 01/2020
1	Gemcitabine FDA Link 01/2018
1	pazopanib FDA Link 01/2018
1	AnthracyclinesIBA 01/2018
1	Untranslated RNA (Noncoding RNA)IBA 07/2017
1	CrizotinibIBA 11/2016
1	DNA Transposable Elements (Element, IS)IBA 09/2016
1	Pharmaceutical PreparationsIBA 01/2016

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 07/2022 - 01/2016
2	Combined Modality Therapy 07/2017 - 01/2016
1	Therapeutics 01/2016